{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:59:08Z","timestamp":1762505948781,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.urolonc.2012.04.011","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T02:27:37Z","timestamp":1341541657000},"page":"1812-1819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fas expression in nephrectomized, non-cancerous specimens predicts post-nephrectomy chronic kidney disease progression in patients with renal and upper urinary tract malignancies"],"prefix":"10.1016","volume":"31","author":[{"given":"Takehiro","family":"Sejima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Morizane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Hinata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiro","family":"Isoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Amisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2012.04.011_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2010.11.013","article-title":"Adverse renal outcomes in subjects undergoing nephrectomy for renal tumors: A population-based analysis","volume":"59","author":"Klarenbach","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.04.011_bib2","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/cncr.25043","article-title":"Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy","volume":"116","author":"Lane","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2012.04.011_bib3","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.juro.2010.12.036","article-title":"Impact of kidney disease outcomes quality initiative guidelines on the prevalence of chronic kidney disease after living donor nephrectomy","volume":"185","author":"Tan","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.04.011_bib4","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.transproceed.2009.11.054","article-title":"Risk factors for deterioration of renal function after donor nephrectomy","volume":"42","author":"Nozaki","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.urolonc.2012.04.011_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1440-1797.2007.00852.x","article-title":"Risk factors for MDRD-GFR of less than 60 mL\/min per 1.73 m2 in former kidney donors","volume":"12","author":"Lee","year":"2007","journal-title":"Nephrol Carlton"},{"key":"10.1016\/j.urolonc.2012.04.011_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2012.04.011_bib7","first-page":"273","article-title":"Genesis of renal tubular atrophy in experimental hydronephrosis in the rat","volume":"56","author":"Gobe","year":"1987","journal-title":"Lab Invest"},{"key":"10.1016\/j.urolonc.2012.04.011_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/B:MCBI.0000021346.03260.7e","article-title":"Evidence of apoptosis in human diabetic kidney","volume":"259","author":"Kumar","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.urolonc.2012.04.011_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ki.1996.14","article-title":"Apoptosis in glomerular sclerosis","volume":"49","author":"Sugiyama","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.urolonc.2012.04.011_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000044986","article-title":"Detection of apoptotic cells in glomeruli of patients with IgA nephropathy","volume":"79","author":"Tashiro","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.urolonc.2012.04.011_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00428-003-0827-x","article-title":"Glomerular cell apoptosis in human lupus nephritis","volume":"443","author":"Makino","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2012.04.011_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1582-4934.2001.tb00135.x","article-title":"Contribution of apoptotic cell death to renal injury","volume":"5","author":"Ortiz","year":"2001","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.urolonc.2012.04.011_bib13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2214\/ajr.130.4.731","article-title":"Sensitivity of gray scale ultrasound in detecting urinary tract obstruction","volume":"130","author":"Ellenbogen","year":"1978","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.urolonc.2012.04.011_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1442-2042.2006.01265.x","article-title":"Significance of Fas expression alteration during tumor progression of renal cell carcinoma","volume":"13","author":"Sejima","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2012.04.011_bib15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1464-410X.2010.09516.x","article-title":"Perioperative morbidity and renal function in young and elderly patients undergoing elective nephron-sparing surgery or radical nephrectomy for renal tumours larger than 4 cm","volume":"107","author":"Roos","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2012.04.011_bib16","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.juro.2010.06.011","article-title":"Renal functional outcomes after partial nephrectomy with extended ischemic intervals are better than after radical nephrectomy","volume":"184","author":"Lane","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.04.011_bib17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2012.04.011_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2012.04.011_bib19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4065\/83.10.1101","article-title":"Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors","volume":"83","author":"Pettus","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.urolonc.2012.04.011_bib20","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","article-title":"The Fas death factor","volume":"267","author":"Nagata","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2012.04.011_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.iy.10.040192.001411","article-title":"Apoptosis and programmed cell death in immunity","volume":"10","author":"Cohen","year":"1992","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.urolonc.2012.04.011_bib22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/370650a0","article-title":"Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways","volume":"370","author":"Lowin","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2012.04.011_bib23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","article-title":"Bcl-2 gene promotes hemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells","volume":"335","author":"Vaux","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2012.04.011_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/348334a0","article-title":"Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death","volume":"348","author":"Hockenbery","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2012.04.011_bib25","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1038\/ki.1995.487","article-title":"Expression of Fas antigen and Bcl-2 in human glomerulonephritis","volume":"48","author":"Takemura","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.urolonc.2012.04.011_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1440-1797.2005.00397.x","article-title":"Expression of Fas, Bcl-2 and p53 molecules in glomerulonephritis and their correlations with clinical and laboratory findings","volume":"10","author":"U\u011fuz","year":"2005","journal-title":"Nephrol Carlton"},{"key":"10.1016\/j.urolonc.2012.04.011_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2249.2006.03219.x","article-title":"Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: Preliminary findings","volume":"146","author":"Fathi","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.urolonc.2012.04.011_bib28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.juro.2009.12.030","article-title":"Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses","volume":"183","author":"Weight","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.04.011_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.juro.2008.09.017","article-title":"Partial nephrectomy versus radical nephrectomy in patients with small renal tumors\u2014is there a difference in mortality and cardiovascular outcomes?","volume":"181","author":"Huang","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.04.011_bib30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cncr.23218","article-title":"Urologic diseases in America project","volume":"112","author":"Miller","year":"2008","journal-title":"Cancer"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912001524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912001524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:04:05Z","timestamp":1761041045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143912001524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1078143912001524"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.04.011","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fas expression in nephrectomized, non-cancerous specimens predicts post-nephrectomy chronic kidney disease progression in patients with renal and upper urinary tract malignancies","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}